Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 3/20 | 1.00 |
| ▸ | ACHE | P22303 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PDPK1 | O15530 | 2/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
| ▸ | PSEN1 | P49768 | 4/20 | 0.39 |
| ▸ | PSEN2 | P49810 | 4/20 | 0.39 |
| ▸ | APH1B | Q8WW43 | 4/20 | 0.39 |
| ▸ | NCSTN | Q92542 | 4/20 | 0.39 |
| ▸ | APH1A | Q96BI3 | 4/20 | 0.39 |
| ▸ | PSENEN | Q9NZ42 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | NT5E | P21589 | 1/20 | 0.36 |
| ▸ | CCKBR | P32239 | 1/20 | 0.36 |
| ▸ | CDC7 | O00311 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18961290 | 1.00 | BCHE (1.00) | BCHEACHELMNAPDPK1MTOR | |
| SCHEMBL20625899 | 0.81 | BCHE (0.68) | BCHEACHEPDPK1MTORPSEN1 | |
| SCHEMBL9547986 | 0.78 | BCHE (0.64) | BCHEACHELMNAPDPK1MTOR | |
| SCHEMBL23995897 | 0.77 | BCHE (0.62) | BCHEACHEPDPK1MTORPSEN1 | |
| SCHEMBL17925924 | 0.77 | BCHE (0.62) | BCHEACHEPDPK1MTORPSEN1 | |
| SCHEMBL19348356 | 0.76 | BCHE (0.61) | BCHEACHELMNAPDPK1MTOR | |
| SCHEMBL17241765 | 0.76 | BCHE (0.61) | BCHEACHELMNAPDPK1MTOR | |
| SCHEMBL17241776 | 0.76 | BCHE (0.61) | BCHEACHELMNAPDPK1MTOR | |
| SCHEMBL4182846 | 0.75 | BCHE (0.59) | BCHEACHEPDPK1MTORPSEN1 | |
| SCHEMBL22330780 | 0.72 | BCHE (0.56) | BCHEACHELMNAPDPK1MTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220125056-A1 | TEMPLATED ANTIMICROBIAL MICROGELS AND METHODS OF MAKING AND USING THE SAME | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220125056-A1 | TEMPLATED ANTIMICROBIAL MICROGELS AND METHODS OF MAKING AND USING THE SAME | MGAM, CD14, CD68 | BCHE 1184/4885ACHE 1222/4885LMNA 3925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.